News

The Government has added a life-changing new eczema medicine to the Pharmaceutical Benefits Scheme (PBS). The $270 million in funding to list the medicine will help up to 3,600 Australians over 12 years of age living with severe eczema.

The second phase of the Australian Government's COVID-19 vaccination campaign has launched. Find out more about the campaign, including when different priority groups will receive the vaccine.

The Australian Government is investing $100 million into the development of new technologies to improve the diagnosis and treatment of stroke, epilepsy and lung disease, including COVID-19.

Find out more about the launch of Australia's COVID-19 vaccination program.

A statement from the Infection Control Expert Group (ICEG) on transmission of SARS-CoV-2.

Find out who the initial doses of COVID-19 vaccine will go to.

The COVID-19 vaccine rollout is starting in February. Getting a vaccine is a safe and effective way of protecting yourself from getting really sick from COVID-19. Encourage your family, Elders and community to get vaccinated when it is their turn so they are protected from it as well.

Are you a healthcare professional caring for Aboriginal and Torres Strait Islander people?
You could be eligible for EarTrain: a series of free training modules on how to identify, manage and treat ear disease and hearing loss.

Boost your COVID-19 awareness with online infection control training. It’s quick to do and costs nothing.
Find out how a whole team of day care educators used it to bump up their knowledge and confidence to manage their COVID-19 health policies.

Healthy relationships and safe sex – that was the message this National Condom Day marked on 14 February. It’s also a good reminder there’s no shame in asking for a sexually transmitted infection (STI) check.

The Therapeutic Goods Administration (TGA) has provisionally approved the Oxford/AstraZeneca COVID-19 vaccine for use in Australia.

More than 142,000 doses of the Pfizer/BioNTech COVID-19 vaccine have arrived at Sydney airport in a major milestone in Australia’s response to the pandemic. Read more about how the vaccines will be rolled out.

You can provide comments through public webinars that will be held between 16 February 2021 and 30 March 2021.

The Australian Government Chief Medical Officer has declared the Greater Melbourne area a COVID-19 hotspot for the purposes of Commonwealth support.

The Australian Government is providing $7 million through the Medical Research Future Fund for research into neurofibromatosis.

Clinicians, academics and consumers are invited to express their interest in participating in the MBS ECG Review Committee, which will review changes to MBS ECG items introduced on 1 August 2020 following implementation of recommendations from the MBS Review Taskforce.

New information about the COVID-19 vaccine rollout to residential aged care facilities is now available.

Read the Prime Minister’s update following the National Cabinet meeting on 5 February 2021.

We invite you to share your views on the proposed approach to making mitochondrial donation available in Australia. The government wants to introduce mitochondrial donation so this lifesaving technology is made available in Australia for some families impacted by severe mitochondrial disease.

Australia has secured an extra 10 million doses of the Pzifer/BioNTech COVID-19 vaccine, bringing the total number of doses of this vaccine to 20 million.

An updated statement from the Australian Health Protection Principal Committee (AHPPC) on on minimising the potential risk of COVID-19 transmission in schools.

The Prime Minister has outlined plans to deliver Australia's COVID-19 vaccination program this year. Find out more.

A campaign to encourage Australians to get the COVID-19 vaccine has begun.

Students in years 7 (year 8 in South Australia) and 10 can receive free vaccinations at school through the National Immunisation Program. Trained and qualified vaccination teams will visit schools to deliver the vaccines throughout the year.

Changes to the NCSP's Guidelines for the clinical management of women at intermediate risk will come into effect from 1 February 2021. This follows the Cancer Council Australia Clinical Guidelines working party review of national data from the renewed program.